glp 1 and dementia Time to with GLP‐1 RAs versus placebo in pooled RCTs. In the Does GLP-1 Help with Dementia?

Data availability The authors declare that data supporting the findings of this study are available within the article and its Supplementary Information files and from the corresponding author upon reasonable request

Reduction of NMDA receptors with dithiothreitol increases [ 3 H]-MK-801 binding and NMDA-induced Ca 2+ fluxes

In rat with the treatment of 10 g/Kg/day BPC 157, the concentration of BPC 157 was estimated to be less than 1 g/ml in the blood which was too low to cause hypotension or hemodynamic change as demonstrated by the lack of vasodilation in the present study 6

About a third of people on cagrilintide (31.6%) achieved 15% weight loss or more, compared to roughly 1 in 20 (4.7%) on placebo

Recalls & Warnings February 20, 2025 Maker of Zicam Agrees to Pay $6 Million to Settle Lawsuit Over Claims to Shorten Colds The maker of Zicam Cold Remedy products, Church & Dwight Co., Inc., has agreed to pay up to $6 million to settle a class action lawsuit that charged it with promoting the products to reduce the severity of cold symptoms and reduce the duration of colds without reliable scientific evidence

Bicep tendonitis is a stubborn, debilitating injury, and the slow pace of natural healing has made it a prime target for regenerative research